Literature DB >> 35359255

Daily physical activity measured by a wearable activity monitoring device in patients with rheumatoid arthritis.

Masahiro Tada1, Yutaro Yamada2, Koji Mandai3, Yoshinari Matsumoto4,5, Noriaki Hidaka6.   

Abstract

INTRODUCTION: Activities of daily living in patients with rheumatoid arthritis (RA) have been evaluated by patient-reported outcomes. However, it has been difficult to measure activity intensity quantitively. Calories expended, exercise, and steps were measured quantitively by a wearable activity meter, and their associations with patients' background characteristics were examined.
METHODS: Data from a prospective, observational study (CHIKARA study) were used. Eighty-five of 100 RA patients were entered and wore a wearable activity meter for 7 days. The daily calories expended and exercise for both walking and housework and steps were evaluated. Total daily calories expended and exercise was defined as the sum of walking and housework. The relationships of DAS28-ESR, mHAQ, body composition, muscle function, and general status were analyzed.
RESULTS: The median age was 66.0 years, and the disease duration was 5.3 years. DAS28-ESR was 3.11, and mHAQ was 0.125. Total daily calories expended, exercise, and number of steps were 461.7 kcal, 3.97 METs h, and 4,788, respectively. MHAQ, walking speed, power, locomotive syndrome, and frailty were independently related to exercise. Total daily exercise and steps of the moderate and high disease activity group were significantly lower than those of the remission group. When the number of steps was < 3,333 and < 2,468, the odds ratios for locomotive syndrome and frailty increased 14.4-fold and 8.7-fold, respectively, using Fisher's exact test (P < 0.001).
CONCLUSIONS: Daily physical activity and number of steps were significantly decreased in RA patients with moderate and high disease activity as measured by a wearable activity meter. Key Points • Total daily calories expended and exercise for both walking and housework and steps in patients with rheumatoid arthritis were 461.7 kcal, 3.97 METs h, and 4,788, respectively, using a wearable activity meter. • Daily physical activity, especially total daily exercise and number of steps, was significantly decreased in RA patients with moderate and high disease activity. • When total daily steps were < 3,333 and < 2,468, the odds ratios for locomotive syndrome and frailty increased 14.4-fold and 8.7-fold, respectively.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Disease activity; Frailty; Housework; Rheumatoid arthritis; Walking

Mesh:

Year:  2022        PMID: 35359255     DOI: 10.1007/s10067-022-06147-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  18 in total

1.  The relationship between physical fitness and ambulatory activity in very elderly women with normal functioning and functional limitations.

Authors:  Daisuke Yoshida; Masaki Nakagaichi; Kazuto Saito; Sawako Wakui; Yutaka Yoshitake
Journal:  J Physiol Anthropol       Date:  2010       Impact factor: 2.867

2.  Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study.

Authors:  Noriko Yoshimura; Shigeyuki Muraki; Toshiko Iidaka; Hiroyuki Oka; Chiaki Horii; Hiroshi Kawaguchi; Toru Akune; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Metab       Date:  2019-06-20       Impact factor: 2.626

3.  Loss of lean body mass affects low bone mineral density in patients with rheumatoid arthritis - results from the TOMORROW study.

Authors:  Tadashi Okano; Kentaro Inui; Masahiro Tada; Yuko Sugioka; Kenji Mamoto; Shigeyuki Wakitani; Tatsuya Koike; Hiroaki Nakamura
Journal:  Mod Rheumatol       Date:  2017-03-07       Impact factor: 3.023

4.  Real-time estimation of daily physical activity intensity by a triaxial accelerometer and a gravity-removal classification algorithm.

Authors:  Kazunori Ohkawara; Yoshitake Oshima; Yuki Hikihara; Kazuko Ishikawa-Takata; Izumi Tabata; Shigeho Tanaka
Journal:  Br J Nutr       Date:  2011-01-25       Impact factor: 3.718

5.  Correlation between frailty and disease activity in patients with rheumatoid arthritis: Data from the CHIKARA study.

Authors:  Masahiro Tada; Yutaro Yamada; Koji Mandai; Noriaki Hidaka
Journal:  Geriatr Gerontol Int       Date:  2019-10-22       Impact factor: 2.730

6.  Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.

Authors:  N Yoshimura; S Muraki; H Oka; T Iidaka; R Kodama; H Kawaguchi; K Nakamura; S Tanaka; T Akune
Journal:  Osteoporos Int       Date:  2016-11-24       Impact factor: 4.507

7.  Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.

Authors:  T Pincus; J A Summey; S A Soraci; K A Wallston; N P Hummon
Journal:  Arthritis Rheum       Date:  1983-11

8.  Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II.

Authors:  Qian-Li Xue; Karen Bandeen-Roche; Ravi Varadhan; Jing Zhou; Linda P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-09       Impact factor: 6.053

9.  Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - results from the CHIKARA study.

Authors:  Masahiro Tada; Yutaro Yamada; Koji Mandai; Noriaki Hidaka
Journal:  Int J Rheum Dis       Date:  2018-09-05       Impact factor: 2.454

10.  Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire.

Authors:  Boulos Haraoui; Josef S Smolen; Daniel Aletaha; Ferdinand C Breedveld; Gerd Burmester; Catalin Codreanu; José Pereira Da Silva; Maarten de Wit; Maxime Dougados; Patrick Durez; Paul Emery; João Eurico Fonseca; Allan Gibofsky; Juan Gomez-Reino; Winfried Graninger; Vedat Hamuryudan; Maria José Jannaut Peña; Joachim Kalden; Tore K Kvien; Ieda Laurindo; Emilio Martin-Mola; Carlomaurizio Montecucco; Pedro Santos Moreno; Karel Pavelka; Gyula Poor; Mario H Cardiel; Ewa Stanislawska-Biernat; Tsutomu Takeuchi; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-07-29       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.